Clinical trials
SARS-CoV Infection clinical trials
Below are recruiting sars-cov infection clinical trials, each written for real people, not researchers. We’re tracking 63 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06679140RecruitingPhase 3
Study of Ibuzatrelvir for COVID-19 in high-risk patients
This trial tests if a new medicine called ibuzatrelvir can help people with COVID-19 who have certain health risks avoid severe illness. It is for patients who cannot or choose not to take another COVID-19 pill called Paxlovid.
Little Rock, ArkansasAges 12 years+ - NCT05656105RecruitingEarly Phase 1
PET scan study of brain inflammation after COVID
This early-phase study uses a special PET scan to look for signs of brain inflammation in people with ongoing (long-term) nervous system symptoms after COVID-19. It may help researchers understand what is driving symptoms and whether this imaging approach can detect inflammation.
Birmingham, AlabamaAges 18–65 - NCT04392401Recruiting
Study immune changes in adults during ICU stay for COVID-19
This study looks at how your immune system responds while you’re in the intensive care unit (ICU) for COVID-19. Researchers will collect samples early in the ICU stay to better understand immune changes during the illness.
BronAges 18 years+ - NCT07605520RecruitingEarly Phase 1
COVID-19 Booster Vaccine Study for Previously Vaccinated Adults
This study tests new COVID-19 booster vaccine candidates in healthy adults who previously received mRNA COVID-19 vaccines. Researchers will monitor safety and how well your immune system responds to help develop better COVID-19 protection.
CréteilAges 18–65 - NCT05384561Recruiting
Training your sense of smell to help after COVID
This trial studies whether structured smell (olfactory) training can improve ongoing smell problems after COVID-19. It may help people whose sense of smell hasn’t fully returned long after the infection.
Trois-Rivières, QuebecAges 18 years+ - NCT07397455RecruitingPhase 1
COVID-19 Omicron Human Challenge Study
This study is a 'human challenge' trial where healthy volunteers who have been vaccinated and have low antibody levels are deliberately exposed to a newer Omicron variant of COVID-19. The goal is to learn how the virus spreads and how to test treatments or vaccines.
LondonAges 18–50 - NCT04429594Recruiting
Study tracking COVID-19 infection rates in the public
This study looks at how often SARS-CoV-2 (the virus that causes COVID-19) infection happens in people who may have been exposed in the community. It may help researchers understand infection rates and patterns in the general population.
NiceAges 18 years+ - NCT04442789Recruiting
Study of lasting effects after COVID-19 hospitalization
This study looks at what health problems remain after a person was hospitalized for COVID-19. It may help doctors understand these long-lasting effects and how to care for people afterward.
GiessenAges 18 years+ - NCT04448145Recruiting
Study why COVID lasts after recovery
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
New York, New YorkAges 7 years+ - NCT04494776Recruiting
Study of COVID-19 in kidney transplant patients
This study looks at what happens when people with kidney transplants get COVID-19. It may help improve how doctors monitor and manage COVID-19 in transplant recipients.
São Paulo, Aão PauloAges Any age - NCT04579471Recruiting
Study COVID-19 infection in people after organ or bone marrow transplant
This study looks at how common COVID-19 (SARS-CoV-2) infection is and what outcomes happen in people who have had a transplant. It may help doctors understand what to expect and how to better support transplant patients during COVID-19.
Leuven, Vlaams BrabantAges 18–90 - NCT04679584Recruiting
Study of long-term effects after COVID-19 infection
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
Würzburg, BavariaAges 18 years+ - NCT04705766Recruiting
Study kidney injury after recent COVID infection
This study looks at how COVID can affect the kidneys soon after infection. You may be able to participate if you recently tested positive for COVID and have not had kidney replacement treatments.
San Francisco, CaliforniaAges 18 years+ - NCT04775134Recruiting
Checking leftover COVID virus after recovery
This study looks for whether small amounts of the COVID virus are still present in the lungs after infection. It may help doctors understand how long the virus can remain and inform future care, using tissue removed during a medically needed lung procedure.
LeuvenAges 18 years+ - NCT04815096RecruitingPhase 2
PET scan study of immune activity after COVID-19
This Phase 2 study uses a special PET scan to look at how active your immune system is after a recent COVID-19 infection. The goal is to understand what the immune response looks like and whether this imaging approach could help guide care.
San Francisco, CaliforniaAges 18 years+ - NCT05141058RecruitingPhase 1
T cell therapy to help prevent COVID-19 after transplant
This Phase 1 trial tests a donated immune-cell treatment (T cells) to help immunocompromised people fight or resist COVID-19 after they recently received a bone marrow or stem cell transplant. It aims to see if the treatment is safe and if it helps the body respond better to the virus.
Washington D.C., District of ColumbiaAges 2–80 - NCT05566483Recruiting
Study long COVID physiology and cardiopulmonary rehab effects
This study looks at how long COVID affects the body and whether cardiopulmonary rehabilitation improves quality of life and physical function. It may help participants better understand their symptoms and see if a structured rehab program improves daily abilities.
Aurora, ColoradoAges 18 years+ - NCT05835102Recruiting
How nutrition measures may affect COVID-19 outcomes
This study looks at nutrition-related measurements to see how they may relate to how people with COVID-19 do over time. It may help doctors better predict who is at higher or lower risk based on nutrition status.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT05858502Recruiting
Study immune response to COVID-19 and improve testing
This study looks at how the immune system in the body responds to different COVID-19 virus variants. It may help improve how COVID-19 is diagnosed by comparing people who are currently infected and those who are not.
ParisAges 18–65 - NCT05866952Recruiting
Breathing and blood-flow testing in long-COVID symptoms
This trial studies how the lungs’ breathing (airflow) and blood flow may be off in people with long-COVID symptoms like tiredness, shortness of breath, or trouble exercising. It may help researchers understand what’s driving symptoms and what kinds of abnormalities could be targeted.
Boston, MassachusettsAges 18–99 - NCT05886816RecruitingPhase 2
Mitoquinone pills to prevent COVID-19 after risky exposure
This trial tests whether an oral medication (mitoquinone/mitoquinol) taken after a high-risk COVID-19 exposure can help prevent you from becoming sick. It is designed for people who currently have no symptoms but had a significant exposure to someone with confirmed COVID-19.
Dallas, TexasAges 18–65 - NCT05892549Recruiting
Phone-based monitoring to detect worsening COVID-19 early
This study tests whether a phone app that listens to your voice and breathing can spot signs your COVID-19 is getting worse sooner. If you qualify, you’ll use the COVOICE app on your mobile phone for monitoring.
Saint-MandéAges 18 years+ - NCT05916287Recruiting
STANISLAS cohort follow-up visit for heart and kidney health
This study is a follow-up visit for people who joined the STANISLAS family health cohort. Researchers look at how genes and environment may affect heart and kidney (kidneys) health over time.
Vandœuvre-lès-Nancy, LorraineAges Any age - NCT05973084Recruiting
COVID spread study in Malawi households and vaccine recipients
This study tracks how COVID-19 spreads and causes illness in real households in Blantyre, Malawi, and compares groups after infection or vaccination. If you qualify, you’ll do follow-up testing and visits for several months.
Boston, MassachusettsAges 5–75
Hear when a new SARS-CoV Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for sars-cov infection?
- Yes. Clin2 currently lists 63 recruiting sars-cov infection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a sars-cov infection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a sars-cov infection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.